MX2018004994A - Formulaciones con liberacion controlada de perfumes para aplicacion dermica. - Google Patents

Formulaciones con liberacion controlada de perfumes para aplicacion dermica.

Info

Publication number
MX2018004994A
MX2018004994A MX2018004994A MX2018004994A MX2018004994A MX 2018004994 A MX2018004994 A MX 2018004994A MX 2018004994 A MX2018004994 A MX 2018004994A MX 2018004994 A MX2018004994 A MX 2018004994A MX 2018004994 A MX2018004994 A MX 2018004994A
Authority
MX
Mexico
Prior art keywords
formulations
perfumes
controlled release
dermal application
copolymers
Prior art date
Application number
MX2018004994A
Other languages
English (en)
Inventor
Pelzer Ralf
Kolter Karl
BENDEL Marion
Karl Matthias
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of MX2018004994A publication Critical patent/MX2018004994A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8135Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Seasonings (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)

Abstract

La invención se refiere a formulaciones de agente perfumante y aromatizante para aplicaciones tópicas, dichas formulaciones contienen como formador de matrices, una mezcla de al menos un polí­mero no hidrosoluble del grupo que contiene homopolí­meros o copolí­meros de ósteres de vinilo de ácido C1-C4-carboxí­lico y al menos un polí­mero hidrosoluble del grupo que contiene homopolí­meros o copolí­meros de N-viniIIactamas.
MX2018004994A 2015-10-23 2016-10-13 Formulaciones con liberacion controlada de perfumes para aplicacion dermica. MX2018004994A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15191157 2015-10-23
PCT/EP2016/074595 WO2017067843A1 (de) 2015-10-23 2016-10-13 Formulierungen mit kontrollierter freisetzung von geruchsstoffen zur dermalen anwendung

Publications (1)

Publication Number Publication Date
MX2018004994A true MX2018004994A (es) 2018-07-06

Family

ID=54360111

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018004994A MX2018004994A (es) 2015-10-23 2016-10-13 Formulaciones con liberacion controlada de perfumes para aplicacion dermica.

Country Status (8)

Country Link
US (1) US11123282B2 (es)
EP (1) EP3364943B1 (es)
JP (1) JP7063806B2 (es)
CN (1) CN108135840A (es)
BR (1) BR112018006406B1 (es)
ES (1) ES2889905T3 (es)
MX (1) MX2018004994A (es)
WO (1) WO2017067843A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017097806A1 (en) 2015-12-08 2017-06-15 Basf Se A tin-containing zeolitic material having a bea framework structure
US10835456B2 (en) 2016-07-19 2020-11-17 Basf Se Propyl gallate-containing vitamin preparations

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US384034A (en) * 1888-06-05 Card-hanger
CH675966A5 (es) 1987-02-20 1990-11-30 Firmenich & Cie
EP0384034A3 (fr) * 1989-02-21 1990-12-27 Firmenich Sa Composition parfumante à action désodorisante ou antiperspirante
NZ244439A (en) * 1991-09-25 1994-01-26 Fisons Plc Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed
US5508259A (en) 1993-02-11 1996-04-16 Firmenich Sa Perfuming composition
WO1998052527A1 (en) 1997-05-21 1998-11-26 Quest International B.V. Perfume fixatives comprising polyvinylpyrrolidone and hydroxypropyl cellulose
DE10029201A1 (de) * 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
CN1193048C (zh) * 2000-09-29 2005-03-16 巴斯福股份公司 聚合物水分散体
US20040175404A1 (en) 2002-04-15 2004-09-09 Adi Shefer Moisture triggered sealed release system
US7235261B2 (en) * 2002-06-27 2007-06-26 Haarmann & Reimer Corporation Controlled release encapsulation
ATE531368T1 (de) * 2003-08-29 2011-11-15 Veloxis Pharmaceuticals As Tacrolimus enthaltende zusammensetzungen mit modifizierter freisetzung
EP1680071A1 (en) 2003-10-02 2006-07-19 Firmenich SA Controlled delivery system for fragrance comprising a (meth)acrylate/hydroxy(meth)acrylate copolymer
CN101090702B (zh) * 2003-10-03 2011-06-08 宝洁公司 局部用组合物
WO2006101536A1 (en) * 2004-11-04 2006-09-28 Akina, Inc. Fast-melting tablets having taste-masking and sustained release properties
JP5159095B2 (ja) * 2005-11-11 2013-03-06 旭化成ケミカルズ株式会社 活性成分の溶出を徐放性に制御する固形製剤
JP2008081465A (ja) * 2006-09-28 2008-04-10 Catalysts & Chem Ind Co Ltd フレグランス組成物
JP2008156236A (ja) * 2006-12-20 2008-07-10 Lion Corp デオドラント組成物
US10226405B2 (en) * 2009-09-18 2019-03-12 International Flavors & Fragrances Inc. Purified polyurea capsules, methods of preparation, and products containing the same
TWI435733B (zh) * 2010-01-29 2014-05-01 Colgate Palmolive Co 用於口臭控制之口腔保健調配物
CN103320226A (zh) * 2013-06-03 2013-09-25 吴江市利达上光制品有限公司 一种香精复合乳化剂及制备方法
US20170216166A1 (en) * 2014-10-01 2017-08-03 International Flavors & Fragrances Inc. Capsules containing polyvinyl alcohol

Also Published As

Publication number Publication date
EP3364943B1 (de) 2021-06-23
US11123282B2 (en) 2021-09-21
BR112018006406B1 (pt) 2022-01-18
EP3364943A1 (de) 2018-08-29
JP7063806B2 (ja) 2022-05-09
ES2889905T3 (es) 2022-01-14
US20190060209A1 (en) 2019-02-28
CN108135840A (zh) 2018-06-08
BR112018006406A2 (pt) 2018-10-09
WO2017067843A1 (de) 2017-04-27
JP2018534292A (ja) 2018-11-22

Similar Documents

Publication Publication Date Title
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2017007299A (es) Composiciones en suspension de liberacion prolongada gastroretentivas.
WO2016011306A3 (en) Terminal modifications of polynucleotides
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
PH12016501122A1 (en) Delayed release compositions of linaclotide
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
MY192425A (en) Polymorphs
PH12016502002B1 (en) Novel bacteriophage and composition comprising same
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
EP3353228A4 (en) POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2-BIS (HYDROXYMETHYL) ALKYLCARBOXYLIC ACID
EP3816266A4 (en) SS-HYDROXYISOBUTIC ACID ESTER COMPOUND, PERFUME COMPOSITION AND USE AS A PERFUME
WO2015171738A3 (en) Fragrance compositions
ZA201806766B (en) Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
MY195509A (en) Pharmaceutical Formulations for Sustained Release of Sebacoyl Dinalbuphine Ester
PH12018500695A1 (en) Oral care compositions and methods of using the compositions
MX2018004994A (es) Formulaciones con liberacion controlada de perfumes para aplicacion dermica.
MX358078B (es) Acido (s)-3'-metil-abscisico y esteres del mismo.
MX2018010387A (es) Preparacion que contiene esomeprazol.
EP3699250A4 (en) COMPOSITION PROVIDING A FRESHNESS FEELING CONTAINING A DERIVATIVE OF 2,2,6-TRIMETHYLCYLCYCLOHEXANECARBOXYLIC ACID
MX2016014216A (es) Composiciones, metodos para producir una composicion, y metodos de uso.
WO2016197042A8 (en) Modified or targeted release formulations of linaclotide
EP3480181A4 (en) AGRICULTURAL COMPOSITION, PELLETS AND EXTENDED RELEASE GRANULES
EP3378495A4 (en) COMPOSITION WITH NOVEL GLUTAMIC ACID DERIVATIVE AND BLOCK COPOLYMER AND USE THEREOF